George Ansstas MD

Physician

4921 Parkview Pl# DvSt. Louis, MO 63110
Phone+1 800-647-2098
Fax+1 314-362-3192

Dr. Ansstas is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ansstas' full profile Already have an account?

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2008 - 2011
SSM Health/Saint Louis University School of MedicineResidency, Internal Medicine, 2004 - 2007
University of Tichreen Faculty of MedicineClass of 2001
Bin Ziad High SchoolB.S., Science, 1992 - 1995

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

IL State Medical License 2018 - 2029
MO State Medical License 2007 - 2027
CA State Medical License 2020 - 2024
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2016-2017
CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2016-2017
Best Teaching Award Washington University School of Medicine, 2016

Clinical Trials

Optune Device - TT Field Plus Nivolumab and Ipilimumab for Melanoma With Brain Metastasis Start of enrollment: 2019 Oct 14
TERMINATED
PHASE2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma Start of enrollment: 2020 May 29
RECRUITING
PHASE2

Publications & Presentations

PubMed

NT-I7, a Long-Acting Interleukin 7, Increases Lymphocyte Counts and Induces CD8+ T-cell Clonotype Expansion in Patients with Newly Diagnosed High-Grade Gliomas.
Omar H Butt, Kartik Singhal, Jingqin Luo, Michael P Rettig, Jennifer A Foltz
Clinical Cancer Research. 2026-07-01
Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase IIb KEYNOTE-942 Study.
Adnan Khattak, Matteo S Carlino, Tarek Meniawy, George Ansstas, Matthew H Taylor
Journal of Clinical Oncology. 2026-06-01
1 citations
Longitudinal ctDNA Monitoring for Postsurgical Disease Surveillance in Patients with Stage I to IIIB Melanoma.
George Ansstas, Karam Khaddour, Sumedha Sudhaman, Karen Lin, Griffin L Budde
Clinical Cancer Research. 2026-04-15

Journal Articles

Pseudoprogression and Radiation Necrosis in Adult Brain Tumor Patients Treated With Proton Beam Radiation Therapy
Marshall Meeks, BS, Sahaja Acharya, MD, Jiayi Huang, MD, Clifford Robinson, MD, Stephanie Perkins, MD, Michael Chicoine, MD, Jian Campian, MD, George Ansstas, MD, Alb..., Oncology (Williston Park), 1/11/2016
Treatment with Tumor Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-refractory Recurrent Glioblastoma: A Case Series
Ansstas G, Tran D, Case Rep Neurol, 1/1/2016
Trends in utilization and impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: A review of the National Can...
Jiayi Huang, Pamela Parker Samson, Stephanie Mabry Perkins, George Ansstas, Milan Chheda, Cliff Grant Robinson, Jian Li Campian, J Clin Oncol, 1/1/2016

Books/Book Chapters

PPO Oncology Review book
Chapter: Neuro-Oncology
George AnsstasDevita book2016
The Washington Manual of Internal Medicine
Chapter: hematological malignancies
George AnsstasLippincott2013
Washington Manual of Hematology and Oncology subspecialty Consult
Chapter: Head and neck Cancers
George AnsstasLippincott2012

Abstracts/Posters

Rheumatoid arthritis presenting as pulmonary hypertension and vocal cord paralysis without joint manifestation in neurofibromatosis patient.
George Ansstas, ACP Meeting, Missouri Chapter, 1/1/2008
Recurrent respiratory papillomatosis as a cause of pulmonary cavitary lesions.
Ali Pakravan, Yousef Assioun, George Ansstas, ACP Meeting, Missouri Chapter,, 1/1/2006

Lectures

Clinical Features of Immune Checkpoint Inhibitor-Associated Autoimmune Hemolytic Anemia: A Series of 14 Cases
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Prospective phase II study of tumor response assessment by CT and FDG-PET/CT following 8 weekly doses of Cetuximab in patients with metastatic/recurrent head and neck ...
1/3/2011
Decitabine For Older AML Patients: An Effective Therapy Associated with Short Hospitalization and No Invasive Fungal Infection.
1/4/2010

Other

Gynecomastia, Review Article
Ansstas,G, E-Medicine Online Publication
1/1/2012
Factor inhibitor assay, Review Article
Ansstas,G, E-Medicine Online Publication
1/1/2012
Factor X, Review Article
Ansstas,G, E-Medicine Online Publication
1/1/2012

Press Mentions

St. Louis Medical Experts Are Making Advances in Cancer CareAugust 14th, 2024
Arming Immune Foot Soldiers Against CancerMay 13th, 2020
NantKwest Hosting Key Opinion Leader Meeting on Novel Immunotherapeutic Approaches to Address the Unmet Medical Needs of Patients with Merkel Cell Carcinoma, Triple-Negative Breast Cancer and Solid TumorsNovember 27th, 2019